Form 4 · Filed May 9, 2026, 01:16 AM UTC
EW/Edwards Lifesciences Corp
Lippis Daniel J. — CVP, TAVR
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
5 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 8, 2026 | F | other | 450 | $83 | $37,242 | 40,773 |
| May 7, 2026 | A | other | 7,850 | $0 | $0 | 41,532 |
| May 7, 2026 | F | other | 309 | $83 | $25,709 | 41,223 |
| May 7, 2026 | A | other | 39,900 | — | — | 39,900 |
| May 7, 2026 | A | other | 7,850 | — | — | 7,850 |
Source: SEC EDGAR raw filing ↗ · Accession 0001225208-26-005045